QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

KMTS

QT67Kestra Medical Technologies, Ltd.
NASDAQ·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
19.93
+0.85+4.45%
OverviewShort InterestFilings
KMTSQT67Kestra Medical Technologies, Ltd.·NASDAQ
OverviewShort InterestFilings
19.93+4.45%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02
Snapshot
Index-P/E-EPS (ttm)-3.96
Insider Own-
Shs Outstand58.37M
Perf Week-1.04%
Market Cap1.11BForward P/E-EPS next Y-1.77Insider Trans-Shs Float-Perf Month0.66%
Enterprise Value826.73MPEG0.07EPS next Q-0.59Inst Own-Short Float-Perf Quarter1.89%
Income-159936447.00P/S13.30EPS this Y44.57%Inst Trans-Short Ratio-Perf Half Y-26.19%
Sales83.72MP/B3.50EPS next Y19.36%ROA-38.18%Short Interest-Perf YTD-24.85%
Book/sh4.93P/C-EPS next 5Y-ROE-68.83%52W High30.00 -33.57%Perf Year32.25%
Cash/sh4.99P/FCF-EPS past 3/5Y-ROIC-42.69%52W Low13.25 50.42%Perf 3Y-
Dividend Est.-EV/EBITDA-6.46Sales past 3/5Y-Gross Margin48.75%Volatility4.05% 4.37%Perf 5Y-
Dividend TTM-EV/Sales9.87EPS Y/Y TTM-65.73%Oper. Margin-171.53%ATR (14)1.43Perf 10Y-
Dividend Ex-Date-Quick Ratio7.32Sales Y/Y TTM200.00%Profit Margin-172.99%RSI (14)48.15Recom-
Dividend Gr. 3/5Y-Current Ratio7.32EPS Q/Q-37.82%SMA20-1.57%Beta1.95Target Price-
Payout-0.02%Debt/Eq0.01Sales Q/Q66.67%SMA50-3.85%Rel Volume1.46Prev Close19.08
Employees300LT Debt/Eq0.21EarningsJul 21SMA200-14.40%Avg Volume272.23KPrice19.93
IPO DateMar 06, 2025Option/ShortYes / YesEPS/Sales Surpr.-4.36% 0.00%Net Debt/EBITDA2.24Volume398,784Change4.45%
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
4/30/2025
FY 2024
4/30/2024
FY 2023
4/30/2023
FY 2021
4/30/2021
FY 2020
4/30/2020
Total Revenue846028
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A443627
Gross Profit41240
Selling, General and Administrative Excl. Other16511570
Research and Development191615
Other Operating Expense100
Operating Income-144-106-85
Interest Expense886
Unusual Expense
———
Non-Operating Income (Expense)-803
Net Income Before Taxes-144-114-94
Income Taxes
000
Consolidated Net Income-145-114-94
Net Income From Continuing Operations-144-114-94
Net Income-145-114-94
EPS (Recurring)-3.96-5.13-2.04
EPS (Basic, Before Extraordinaries)-3.96-5.13-2.04
EPS (Diluted)-3.96-5.13-2.04
EBITDA-127-98-76
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
12.57——
Gross Margin48.8140.000.00
Operating Margin-171.43-176.67-303.57
Net Margin-172.62-190.00-335.71
Shares Outstanding535050
Market Capitalization
1,056——
Operating Lease Expense
———
Insider Trading Volume
$21.95$20.04$18.14$16.23$14.32● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR